Clinical Trials for Adagene

Explore 7 clinical trials worldwide

Showing 1-7 of 7 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Adagene

Clinical Trials (7)

NCT06846268
Neoadjuvant ADG126 and Pembrolizumab in Locally Advanced Colorectal Cancer
PHASE2Recruiting
20 participants
Started: Apr 14, 2025 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05491083
Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer
PHASE1/PHASE2Recruiting
51 participants
Started: Jun 12, 2023 · Completed: Dec 31, 2026
2 conditions3 sponsors1 location
NCT05614258
Study of ADG206 in Subjects With Advanced/Metastatic Solid Tumors
PHASE1Recruiting
21 participants
Started: Feb 13, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor2 locations
NCT05405595
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
PHASE1/PHASE2Recruiting
152 participants
Started: Jun 15, 2022 · Completed: Apr 30, 2027
1 condition2 sponsors17 locations
NCT05275777
A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer
PHASE1/PHASE2Active, not recruiting
66 participants
Started: May 19, 2022 · Completed: Feb 28, 2030
2 conditions2 sponsors1 location
NCT04524871
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)
PHASE1/PHASE2Recruiting
518 participants
Started: Nov 1, 2020 · Completed: Dec 31, 2026
1 condition5 sponsors33 locations
NCT04501276
A Phase 1b/2 Study of ADG116, ADG116 Combined With Anti-PD-1 Antibody or Anti-CD137 Antibody in Solid Tumors Patients
PHASE1Active, not recruiting
72 participants
Started: Sep 23, 2020 · Completed: Feb 1, 2025
1 condition1 sponsor4 locations